VIMTALABSNSEVimta Labs Limited· PharmaceuticalsMediumNeutral
Announced Wed, 6 May · 16:59 IST

Vimta Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 06, 2026.

Management Changes View source PDF

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹510.70
prior close
₹529.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+7.5+4.8+4.0+2.2+0.5-3.7-8.3-8.5-10.3-13.1-7.4+2.4+8.2
Up moveDown movePending
AI summary

Vimta Labs Limited's Board has recommended the re-appointment of Dr. S. P. Vasireddi as Executive Chairman for five years (July 2026 to June 2031), subject to shareholder approval at the ensuing AGM. Dr. Vasireddi, aged 77, is the founder of the company and has been associated with it since inception. He previously served as Chairman & Managing Director until July 2013, then as Executive Chairman until June 2018, Non-Executive Chairman until June 2023, and resumed Executive Chairman role thereafter. His re-appointment requires a special resolution under Section 196(3)(a) of the Companies Act, 2013 due to his age. Dr. Vasireddi holds 51,97,050 equity shares and is the father of Ms. Harita Vasireddi, the Managing Director.

Likely market impact

Positive for the company as the founder and key promoter continues to lead. The special resolution requirement due to his age is a routine compliance matter, not a governance concern.